Terms: = Breast cancer AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Prognosis
43 results:
1. p140Cap modulates the mevalonate pathway decreasing cell migration and enhancing drug sensitivity in breast cancer cells.
Centonze G; Natalini D; Grasso S; Morellato A; Salemme V; Piccolantonio A; D'Attanasio G; Savino A; Bianciotto OT; Fragomeni M; Scavuzzo A; Poncina M; Nigrelli F; De Gregorio M; Poli V; Arina P; Taverna D; Kopecka J; Dupont S; Turco E; Riganti C; Defilippi P
Cell Death Dis; 2023 Dec; 14(12):849. PubMed ID: 38123597
[TBL] [Abstract] [Full Text] [Related]
2. POTEE promotes breast cancer cell malignancy by inducing invadopodia formation through the activation of SUMOylated rac1.
Martínez-López A; García-Casas A; Infante G; González-Fernández M; Salvador N; Lorente M; Mendiburu-Eliçabe M; Gonzalez-Moreno S; Villarejo-Campos P; Velasco G; Malliri A; Castillo-Lluva S
Mol Oncol; 2024 Mar; 18(3):620-640. PubMed ID: 38098337
[TBL] [Abstract] [Full Text] [Related]
3. Identification of Hub Genes and Upstream Regulatory Factors Based on Cell Adhesion in Triple-negative breast cancer by Integrated Bioinformatical Analysis.
Han YH; Wang Y; Lee SJ; Mao YY; Jiang P; Sun HN; Jin MH; Kwon T
Anticancer Res; 2023 Jul; 43(7):2951-2964. PubMed ID: 37351977
[TBL] [Abstract] [Full Text] [Related]
4. An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative breast cancer Progression.
Lu XX; Yang WX; Pei YC; Luo H; Li XG; Wang YJ; Zhang GL; Ling H; Shao ZM; Hu X
Cancer Res; 2023 Jun; 83(12):2000-2015. PubMed ID: 37057875
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Pathology of Micropapillary Carcinomas: Is Characteristic Morphology Related to Molecular Mechanisms?
Sagnak Yilmaz Z; Sarioglu S
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):267-277. PubMed ID: 37036419
[TBL] [Abstract] [Full Text] [Related]
6. The pseudokinase NRBP1 activates rac1/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer.
Yang X; Cruz MI; Nguyen EV; Huang C; Schittenhelm RB; Luu J; Cowley KJ; Shin SY; Nguyen LK; Lim Kam Sian TCC; Clark KC; Simpson KJ; Ma X; Daly RJ
Oncogene; 2023 Mar; 42(11):833-847. PubMed ID: 36693952
[TBL] [Abstract] [Full Text] [Related]
7. EIF4A3-induced circBRWD3 promotes tumorigenesis of breast cancer through miR-142-3p_miR-142-5p/rac1/PAK1 signaling.
Meng X; Li W; Meng Z; Li Y
BMC Cancer; 2022 Nov; 22(1):1225. PubMed ID: 36443711
[TBL] [Abstract] [Full Text] [Related]
8. PACT promotes the metastasis of basal-like breast cancer through rac1 SUMOylation and activation.
Wei L; Wang W; Yao J; Cui Z; Xu Z; Ding H; Wu X; Wang D; Luo J; Ke ZJ
Oncogene; 2022 Sep; 41(37):4282-4294. PubMed ID: 35974143
[TBL] [Abstract] [Full Text] [Related]
9. A Regulatory Axis between Epithelial Splicing Regulatory Proteins and Estrogen Receptor α Modulates the Alternative Transcriptome of Luminal breast cancer.
Elhasnaoui J; Ferrero G; Miano V; Franchitti L; Tarulli I; Coscujuela Tarrero L; Cutrupi S; De Bortoli M
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887187
[TBL] [Abstract] [Full Text] [Related]
10. LncRNA RP11-214F16.8 drives breast cancer tumorigenesis via a post-translational repression on NISCH expression.
Lv X; Zhang Q
Cell Signal; 2022 Apr; 92():110271. PubMed ID: 35108640
[TBL] [Abstract] [Full Text] [Related]
11. BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma.
Mao CG; Jiang SS; Wang XY; Tao SL; Jiang B; Mao CY; Yang YL; Hu ZY; Long T; Jin H; Tan QY; Huang Y; Deng B
Int J Biol Sci; 2021; 17(10):2461-2475. PubMed ID: 34326687
[No Abstract] [Full Text] [Related]
12. rac1-mediated sustained β4 integrin level develops reattachment ability of breast cancer cells after anchorage loss.
Mori K; Higurashi M; Ishikawa F; Shibanuma M
Cancer Sci; 2021 Aug; 112(8):3205-3217. PubMed ID: 34036687
[TBL] [Abstract] [Full Text] [Related]
13. Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro.
Vashum Y; Premsingh R; Kottaiswamy A; Soma M; Padmanaban A; Kalaiselvan P; Samuel S
Mol Biol Rep; 2021 Jan; 48(1):105-116. PubMed ID: 33294960
[TBL] [Abstract] [Full Text] [Related]
14. Silibinin Inhibit Cell Migration through Downregulation of rac1 Gene Expression in Highly Metastatic breast cancer Cell Line.
Lashgarian HE; Adamii V; Ghorbanzadeh V; Chodari L; Kamali F; Akbari S; Dariushnejad H
Drug Res (Stuttg); 2020 Oct; 70(10):478-483. PubMed ID: 32791535
[TBL] [Abstract] [Full Text] [Related]
15. rac1 activation in human breast carcinoma as a prognostic factor associated with therapeutic resistance.
Yamaguchi M; Takagi K; Sato A; Miki Y; Miyashita M; Sasano H; Suzuki T
Breast Cancer; 2020 Sep; 27(5):919-928. PubMed ID: 32314182
[TBL] [Abstract] [Full Text] [Related]
16. Identification of potential key genes for HER-2 positive breast cancer based on bioinformatics analysis.
Lin Y; Fu F; Lv J; Wang M; Li Y; Zhang J; Wang C
Medicine (Baltimore); 2020 Jan; 99(1):e18445. PubMed ID: 31895772
[TBL] [Abstract] [Full Text] [Related]
17. Cullin-3/KCTD10 E3 complex is essential for rac1 activation through RhoB degradation in human epidermal growth factor receptor 2-positive breast cancer cells.
Murakami A; Maekawa M; Kawai K; Nakayama J; Araki N; Semba K; Taguchi T; Kamei Y; Takada Y; Higashiyama S
Cancer Sci; 2019 Feb; 110(2):650-661. PubMed ID: 30515933
[TBL] [Abstract] [Full Text] [Related]
18. GAP43, a novel metastasis promoter in non-small cell lung cancer.
Zhang F; Ying L; Jin J; Feng J; Chen K; Huang M; Wu Y; Yu H; Su D
J Transl Med; 2018 Nov; 16(1):310. PubMed ID: 30419922
[TBL] [Abstract] [Full Text] [Related]
19. Small molecule activator of Nm23/NDPK as an inhibitor of metastasis.
Lee JJ; Kim HS; Lee JS; Park J; Shin SC; Song S; Lee E; Choi JE; Suh JW; Lee H; Kim EE; Seo EK; Shin DH; Lee HY; Lee HY; Lee KJ
Sci Rep; 2018 Jul; 8(1):10909. PubMed ID: 30026594
[TBL] [Abstract] [Full Text] [Related]
20. Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.
Chang JW; Kuo WH; Lin CM; Chen WL; Chan SH; Chiu MF; Chang IS; Jiang SS; Tsai FY; Chen CH; Huang PH; Chang KJ; Lin KT; Lin SC; Wang MY; Uen YH; Tu CW; Hou MF; Tsai SF; Shen CY; Tung SL; Wang LH
Oncogene; 2018 Jul; 37(30):4137-4150. PubMed ID: 29706651
[TBL] [Abstract] [Full Text] [Related]
[Next]
